Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failure
Biotech
Seelos' sugar therapy fails to improve ALS severity in ph. 2/3
Seelos' midstage ALS failure adds more pressure to the biotech's tight cash runway.
Max Bayer
Mar 19, 2024 10:00am
Novocure's electric fields fail phase 3 ovarian cancer trial
Aug 28, 2023 10:15am
Another Flagship biotech focused on the microbiome struggles
Apr 26, 2023 10:45am
Synaptogenix's Alzheimer's prospect flops in NIH-sponsored study
Dec 16, 2022 10:45am
Kaleido calls it quits amid pipeline implosion and mounting debt
Apr 8, 2022 11:17am
ProQR treatment for congenital eye disease flops in trials
Feb 11, 2022 11:30am
